Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

LDN 2019 Conference - Saturday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Sarah Zielsdorf, MD, MS - "Just try LDN": 3 years of insight from over 1000 patients' use of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Sajad Zalzala, MD - What Patients Need to Know About Telemedicine (2019 Conference) (LDN, low dose naltrexone)

Sajad Zalzala, MD discusses what telemedicine is, its use and benefits, and about using LDN Direct telemedicine/LDN prescription business. Some telemedicine regulations are presented, as well as common conditions treated with LDN

LDN 2019 Conference - Friday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Michelle Moser, RPh - Making a difference (2019 Conference) (LDN, low dose naltrexone)

Michelle Moser, RPh discusses the pharmacist’s role in LDN, including information resources for prescribers and customers, and facilitators between the customers and their treatments. She presents an LDN Patient Care Model.

Linda Elsegood - LDN, MS, The LDN Research Trust and Me (2019 Conference) (LDN, low dose naltrexone)

Linda Elsegood, Trustee of the LDN Research Trust, discusses why LDN isn’t widely prescribed, content on the LDN Research Trust website, The LDN Book, and what’s next for the Trust.